Page last updated: 2024-11-11

linogliride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

linogliride: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6536869
CHEMBL ID40356
MeSH IDM0129779

Synonyms (21)

Synonym
linogliride
75358-37-1
linogliride (usan/inn)
D04739
CHEMBL40356
mcn 3935
(ne)-n-(1-methylpyrrolidin-2-ylidene)-n'-phenylmorpholine-4-carboximidamide
linogliridum [latin]
7e521jyj4x ,
linoglirida
n-(1-methyl-2-pyrrolidinylidene)-n'-phenyl-4-morpholinecarboxamidine
linogliridum
unii-7e521jyj4x
linoglirida [spanish]
4-morpholinecarboximidamide, n-(1-methyl-2-pyrrolidinylidene)-n'-phenyl-
linogliride [usan:inn]
linogliride [inn]
linogliride [usan]
DTXSID201024552
n-(1-methyl-2-pyrrolidinylidene)-n'-phenyl-4-morpholinecarboximidamide
AKOS040747103

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"Salts of linogliride with reduced solubilities were prepared and evaluated as potential candidates for extended-release oral dosage forms."( The preparation and evaluation of salt forms of linogliride with reduced solubilities as candidates for extended release.
Ahmad, K; Chrzanowski, FA, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID194310Mean maximum percent lowering of glucose at a single dose of 10 mg/kg, subcutaneously using rat oral glucose tolerance test.1993Journal of medicinal chemistry, May-28, Volume: 36, Issue:11
A novel series of N-(1-aminoalkylidene)carboximidamides as potential hypoglycemic agents.
AID177194Effective dose to produce a 30% maximum decrease of glucose from control1993Journal of medicinal chemistry, May-28, Volume: 36, Issue:11
A novel series of N-(1-aminoalkylidene)carboximidamides as potential hypoglycemic agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (33.33)18.7374
1990's7 (58.33)18.2507
2000's0 (0.00)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (8.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]